BACKGROUND: Low levels of insulinlike growth factor 1 (IGF-I) may influence the development of age-related cardiovascular diseases including congestive heart failure (CHF). Insulinlike growth factor binding protein 1 (IGFBP-1), which increases during catabolic states and inhibits anabolic IGF-I effects, is increased in patients with CHF and has been associated prospectively with increased mortality among older adults and survivors of myocardial infarction. We investigated the association between fasting plasma levels of IGF-I, IGFBP-1, IGFBP-3, and insulin and risk of incident CHF in the prospective Cardiovascular Health Study. METHODS: From among 5,888 adults 65 years old and older in the Cardiovascular Health Study, we studied 566 incident CHF cases and 1,072 comparison subjects after exclusion of underweight individuals (body mass index <18.5 kg/m(2)) and insulin users. Hazard ratios (HRs) with 95% CIs for CHF were estimated after adjustment for age, race, sex, hypertension, systolic blood pressure, lipid levels, left ventricular hypertrophy, coronary disease, C-reactive protein, health status, diabetes, and body mass index. RESULTS: High baseline IGFBP-1 level was a significant predictor of CHF, independent of established CHF risk factors and inflammation markers. The HR per SD of IGFBP-1 was 1.22 (95% CI 1.07-1.39, P < .01). Relative to the lowest IGFBP-1 tertile, the HR was 1.29 (95% CI 0.96-1.74, P = .09) for the second IGFBP-1 tertile and 1.47 (95% CI 1.06-2.04; P = .02) for the highest IGFBP-1 tertile (tertile cut points 19.5 and 35.8 ng/mL). Total IGF-I, IGFBP-3, or insulin levels had no association with CHF after adjustment for CHF risk factors. CONCLUSIONS: High circulating IGFBP-1 level may be a CHF risk factor among older adults.
BACKGROUND: Low levels of insulinlike growth factor 1 (IGF-I) may influence the development of age-related cardiovascular diseases including congestive heart failure (CHF). Insulinlike growth factor binding protein 1 (IGFBP-1), which increases during catabolic states and inhibits anabolic IGF-I effects, is increased in patients with CHF and has been associated prospectively with increased mortality among older adults and survivors of myocardial infarction. We investigated the association between fasting plasma levels of IGF-I, IGFBP-1, IGFBP-3, and insulin and risk of incident CHF in the prospective Cardiovascular Health Study. METHODS: From among 5,888 adults 65 years old and older in the Cardiovascular Health Study, we studied 566 incident CHF cases and 1,072 comparison subjects after exclusion of underweight individuals (body mass index <18.5 kg/m(2)) and insulin users. Hazard ratios (HRs) with 95% CIs for CHF were estimated after adjustment for age, race, sex, hypertension, systolic blood pressure, lipid levels, left ventricular hypertrophy, coronary disease, C-reactive protein, health status, diabetes, and body mass index. RESULTS: High baseline IGFBP-1 level was a significant predictor of CHF, independent of established CHF risk factors and inflammation markers. The HR per SD of IGFBP-1 was 1.22 (95% CI 1.07-1.39, P < .01). Relative to the lowest IGFBP-1 tertile, the HR was 1.29 (95% CI 0.96-1.74, P = .09) for the second IGFBP-1 tertile and 1.47 (95% CI 1.06-2.04; P = .02) for the highest IGFBP-1 tertile (tertile cut points 19.5 and 35.8 ng/mL). Total IGF-I, IGFBP-3, or insulin levels had no association with CHF after adjustment for CHF risk factors. CONCLUSIONS: High circulating IGFBP-1 level may be a CHF risk factor among older adults.
Authors: L P Fried; N O Borhani; P Enright; C D Furberg; J M Gardin; R A Kronmal; L H Kuller; T A Manolio; M B Mittelmark; A Newman Journal: Ann Epidemiol Date: 1991-02 Impact factor: 3.797
Authors: Gina D Schellenbaum; Thomas D Rea; Susan R Heckbert; Nicholas L Smith; Thomas Lumley; Veronique L Roger; Dalane W Kitzman; Herman A Taylor; Daniel Levy; Bruce M Psaty Journal: Am J Epidemiol Date: 2004-10-01 Impact factor: 4.897
Authors: Gysèle S Bleumink; Ingrid Rietveld; Joop A M J L Janssen; Elisabeth F C van Rossum; Jaap W Deckers; Albert Hofman; Jacqueline C M Witteman; Cornelia M van Duijn; Bruno H Ch Stricker Journal: Am J Cardiol Date: 2004-08-01 Impact factor: 2.778
Authors: Gail A Laughlin; Elizabeth Barrett-Connor; Michael H Criqui; Donna Kritz-Silverstein Journal: J Clin Endocrinol Metab Date: 2004-01 Impact factor: 5.958
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan Journal: N Engl J Med Date: 2004-02-12 Impact factor: 91.245
Authors: Timothy P Fitzgibbons; Olga T Hardy; Darleen Lessard; Joel M Gore; Jorge Yarzebski; Robert J Goldberg Journal: Coron Artery Dis Date: 2009-12 Impact factor: 1.439
Authors: Robert C Kaplan; Petra Bùzková; Anne R Cappola; Howard D Strickler; Aileen P McGinn; Laina D Mercer; Alice M Arnold; Michael N Pollak; Anne B Newman Journal: J Clin Endocrinol Metab Date: 2012-03-22 Impact factor: 5.958
Authors: Lora C Bailey-Downs; Danuta Sosnowska; Peter Toth; Matthew Mitschelen; Tripti Gautam; Jim C Henthorn; Praveen Ballabh; Akos Koller; Julie A Farley; William E Sonntag; Anna Csiszar; Zoltan Ungvari Journal: J Gerontol A Biol Sci Med Sci Date: 2011-11-10 Impact factor: 6.053
Authors: Chino S Aneke-Nash; Christina M Parrinello; Swapnil N Rajpathak; Thomas E Rohan; Elsa S Strotmeyer; Stephen B Kritchevsky; Bruce M Psaty; Petra Bůžková; Jorge R Kizer; Anne B Newman; Howard D Strickler; Robert C Kaplan Journal: J Am Geriatr Soc Date: 2015-05 Impact factor: 5.562
Authors: Lora C Bailey-Downs; Matthew Mitschelen; Danuta Sosnowska; Peter Toth; John T Pinto; Praveen Ballabh; M Noa Valcarcel-Ares; Julie Farley; Akos Koller; Jim C Henthorn; Caroline Bass; William E Sonntag; Zoltan Ungvari; Anna Csiszar Journal: J Gerontol A Biol Sci Med Sci Date: 2011-10-21 Impact factor: 6.053
Authors: Chino S Aneke-Nash; Clara Dominguez-Islas; Petra Bůžková; Qibin Qi; Xiaonan Xue; Michael Pollak; Howard D Strickler; Robert C Kaplan Journal: Growth Horm IGF Res Date: 2015-12-08 Impact factor: 2.372
Authors: Robert C Kaplan; Annette L Fitzpatrick; Michael N Pollak; Jeffrey P Gardner; Nancy S Jenny; Aileen P McGinn; Lewis H Kuller; Howard D Strickler; Masayuki Kimura; Bruce M Psaty; Abraham Aviv Journal: J Gerontol A Biol Sci Med Sci Date: 2009-04-06 Impact factor: 6.053
Authors: L Shi; D Banerjee; A Dobierzewska; S Sathishkumar; A A Karakashian; N V Giltiay; M N Nikolova-Karakashian Journal: Am J Physiol Endocrinol Metab Date: 2016-02-16 Impact factor: 4.310
Authors: Dipanjan Banerjee; Mary L Biggs; Laina Mercer; Kenneth Mukamal; Robert Kaplan; Joshua Barzilay; Lewis Kuller; Jorge R Kizer; Luc Djousse; Russell Tracy; Susan Zieman; Donald Lloyd-Jones; David Siscovick; Mercedes Carnethon Journal: Circ Heart Fail Date: 2013-04-10 Impact factor: 8.790